ORAGENICS INC
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
OGEN$0.34-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
| Common Stock · Preferred Stock · Additional Paid in · Accumulated · Total Stockholders’ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · Deficit · Equity | ||||||||
| Balances at December 31, 2025 | 4,271,529 | $4,271 | 7,917,488 | $ | - | $234,905,793 | $(226,628,659) | $8,281,405 |
| Compensation expense relating to options | - | - | - | - | 17,386 | - | 17,386 | |
| Common stock issued for services | 5,000 | 5 | - | - | 4,995 | - | 5,000 | |
| Sale of common stock | 84,700 | 85 | - | - | 79,125 | - | 79,210 | |
| Conversion of Series H Preferred Shares into Common Stock | 14,500 | 14 | (1,000) | - | (14) | - | - | |
| Net loss | - | - | - | - | - | (2,201,243) | (2,201,243) | |
| Balances at March 31, 2026 | 4,375,729 | $4,375 | 7,916,488 | $ | - | $235,007,285 | $(228,829,902) | $6,181,758 |
| Common Stock · Preferred Stock · Additional Paid in · Accumulated · Total Stockholders’ | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · Deficit · Equity | ||||||||
| Balances at December 31, 2024 | 419,003 | $419 | 7,488,197 | $ | - | $216,573,868 | $(216,786,172) | $(211,885) |
| Compensation expense relating to options | - | - | - | - | 17,706 | - | 17,706 | |
| Compensation expense recapture relating to options | - | - | - | - | (86,470) | - | (86,470) | |
| Sale of common stock | 258,849 | 259 | - | - | 2,633,931 | - | 2,634,190 | |
| Conversion of prefunded warrants to common stock | 37,990 | 38 | - | - | 1,102 | - | 1,140 | |
| Issuance of Series G Preferred Stock | - | - | 1,000,000 | - | - | - | - | |
| Net loss | - | - | - | - | - | (2,216,993) | (2,216,993) | |
| Balances at March 31, 2025 | 715,842 | $716 | 8,488,197 | $ | - | $219,140,137 | $(219,003,165) | $137,688 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.